On tonight's MAD MONEY show on CNBC, Jim Cramer had a new pick that is up and, he says, is heading higher. He was blown away by Dolby Laboratories, Inc. (NYSE:DLB) 45% recent climb. He said it is everywhere and in everything you hear. Cramer calls it "the Microsoft of the digital experience."
It closed at $28.95 tonight, up from $23 recently and up from a low of well under $20 over the last year. He thinks the past doesn't matter and this is going higher. The stock soared after its last earnings release, in which the company beat analyst estimates by $0.11 and management guided higher, but he doesn't think it soared enough. The new information they divulged signals to Cramer that the estimates are too low and need to go higher. The estimate is $0.83 to $0.92 projected for next year, but Cramer said he would eat his yellow hard hat if the company doesn't earn $1.07 next year (he then said he thinks they'll do $1.00 next year).
Naturally Dolby is a leader in the music market, but Cramer said this is also a "stealth play" on the new flat panel TV's because the HD requires to have new Dolby-compliant specs. The company has a huge margin on its licensing, and the company has even been able to squeeze royalties out of Microsoft Corporation (NASDAQ:MSFT), not an easy task. The company's balance sheet is strong, with $4.55 in cash per share. It trades with a lower multiple than its growth rate.
For a reference DLB has been public less than two years, and it came public at just under $25.00 in early 2005. DLB has trailing EPS of $0.80 and has a 36 P/E ratio. Now at $30.00 this is a new all-time high.
Last updated: February 13, 2012: 07:45 AM
Hot Stocks
DailyFinance Headlines
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
Benzinga Headlines
- Seven Japanese Stocks Up More Than 10% Year to Date
- Does the 2012 Election Really Matter for the Economy?
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
TheFlyOnTheWall.com Headlines
- Symantec management to meet with UBS
- Boeing: Dreamliner glitch won't slow production, CNBC reports
- NetApp downgraded to Hold from Buy at ThinkEquity
- Pricing for ultrabooks won't hit 'sweet spot' until 2013, DigiTimes says
- EQT Corporation subsidiary files registration statement
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger


Reader Comments (Page 1 of 1)
12-08-2006 @ 1:25AM
Miss Money Maker said...
I agree with Cramer and think Best Buy might also benefit from a spike in sales during the holiday season.
http://financialfrenzy.blogspot.com